Highline Wealth Partners LLC Werewolf Therapeutics, Inc. Transaction History
Highline Wealth Partners LLC
- $372 Billion
- Q3 2025
A detailed history of Highline Wealth Partners LLC transactions in Werewolf Therapeutics, Inc. stock. As of the latest transaction made, Highline Wealth Partners LLC holds 5,000 shares of HOWL stock, worth $4,700. This represents 0.0% of its overall portfolio holdings.
Number of Shares
5,000
Previous 10,000
50.0%
Holding current value
$4,700
Previous $10.9 Million
9.63%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding HOWL
# of Institutions
64Shares Held
22.7MCall Options Held
0Put Options Held
0-
Ra Capital Management, L.P. Boston, MA6.68MShares$6.28 Million0.23% of portfolio
-
Mpm Asset Management LLC Cambridge, MA4.31MShares$4.05 Million19.47% of portfolio
-
Bio Impact Capital LLC Cambridge, MA2.41MShares$2.26 Million0.88% of portfolio
-
Bank Of America Corp Charlotte, NC1.83MShares$1.72 Million0.0% of portfolio
-
Black Rock Inc. New York, NY1.59MShares$1.49 Million0.0% of portfolio
About Werewolf Therapeutics, Inc.
- Ticker HOWL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 29,529,400
- Market Cap $27.8M
- Description
- Werewolf Therapeutics, Inc., a biopharmaceutical company, develops therapeutics engineered to stimulate the body's immune system for the treatment of cancer. The company, through its proprietary PREDATOR platform, designs conditionally activated molecules that stimulate adaptive and innate immunity for addressing the limitations of conventional ...